Expanding Hope for Pediatric Myasthenia Gravis: Jonathan Strober, MD
Accurate Diagnosis of Myasthenia Gravis in Pediatric Patients Is Challenging: Jonathan Strober, MD
Barriers to Timely Diagnosis of Generalized Myasthenia Gravis: Marla Black Morgan, MD
Pediatric Patients With Myasthenia Gravis Need More Treatment Options: Jonathan Strober, MD
Early Diagnosis Vital to Myasthenia Gravis Treatment: Richard J. Nowak, MD, MS
Delays, Disparities in gMG Diagnosis Among Minority Patients: Marla Black Morgan, MD
52-Week MINT Data Confirm Inebilizumab Benefit in AChR+ gMG: Richard Nowak, MD, MS
Dr James Howard Explains Mechanisms of Action of Newer Myasthenia Gravis Therapies
Dr James Howard on the Malfunctions in the Neuromuscular Junction
Unmet Needs in Myasthenia Gravis Are Numerous, Says Dr James Howard
Rozanolixizumab Remains Consistently Safe, Effective for gMG
Sugammadex Safe, Effective Post Surgery in Myasthenia Gravis
Clinical Features Vary Across Myasthenia Gravis Foundation Classes
Enhancing Myasthenia Gravis Care With AI-Powered Telemedicine
SC Efgartigimod Shows Noninferiority to IV Formulation in gMG